This subgroup is in development - please watch this space.
Our lead is Alison Taylor our UKAOS board member with a special interest in MUO. If you wish to be involved then please contact us via this link.
UKAOS are scoping MUO Services in the UK
Dear UKAOS member,
The UK Acute Oncology Society (UKAOS) Malignancy of unknown origin (MUO) subgroup are scoping how patients with MUO start their clinical journey from acute presentation to definitive management. We know that:
- Diagnosis in the emergency setting is often associated with poor prognosis
- Patients are often diagnosed with advanced disease and may require urgent and appropriate symptom management
- Patient experience for this group tends to be poor
- There are often issues with lack of clear defined pathways and ownership of patients
- Acute Oncology Teams often support the MUO pathway and can provide advice and guidance for patients and clinicians can improve patient outcomes and experience
This questionnaire is for all those hospitals that receive acute admissions. The aim is to scope MUO services and pathways across the England, Scotland, Wales and Northern Ireland.
We invite you to complete the questionnaire using the following link ► https://forms.office.com/e/NLceLVNsun
or QR code below:
We appreciate how busy everyone is, but we would be very grateful if you can complete the questionnaire by the end of February 2025.
Please feel free to forward to others contacts too.
Thank you for completing the questionnaire - if you have any questions, please email ukaos@media1productions.co.uk
Alison Taylor Acute Oncology Nurse Consultant UKAOS MUO subgroup lead
Follow this link to see Alison Taylor 's presentation on MUO and CUP practice for the SAM webinar series 2024
|